Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repurposed Ketoconazole in Glioma Patients
NCT07585851Phase 1Active, not recruiting
- Sponsor
- Universitas Padjadjaran
- Start
- Feb 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketoconazole in glioma, sponsored by Universitas Padjadjaran. Primary endpoint: Difference in Ketoconazole Concentrations Between Tumor Tissue and Plasma. Started Feb 2023; status: active, not recruiting.
02
Drugs
ketoconazole
03
Conditions
glioma
Beyond the preview
Go deeper on NCT07585851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07585851.